Romanian Society of Pharmaceutical Sciences
 

« Back to Farmacia Journal 5/2020

PHARMACEUTICAL MARKET OF ANALGESIC MEDICINES IN ROMANIA

IRINA CAZACU 1, ANNIE FOURRIER-RÉGLAT 2, FRANÇOISE HARAMBURU 3, CRISTINA MOGOȘAN 1*, SÎNZIANA GHEORGHE-CETEAN 4, OLIVIU VOȘTINARU 1, FELICIA LOGHIN 5

1.Department of Pharmacology, Physiology and Pathophysiology, Faculty of Pharmacy, “Iuliu Hațieganu” University of Medicine and Pharmacy, 400012, Cluj-Napoca, Romania
2 .Department of Pharmacology, University of Bordeaux, INSERM U657, 33000, Bordeaux, France
3 .Department of Pharmacology, Regional Pharmacovigilance Centre, CHU de Bordeaux, INSERM U657, 33000, Bordeaux, France
4 .Department of General and Inorganic Chemistry, Faculty of Pharmacy, “Iuliu Hațieganu” University of Medicine and Pharmacy, 400012, Cluj-Napoca, Romania
5 .Department of Toxicology, Faculty of Pharmacy, “Iuliu Hațieganu” University of Medicine and Pharmacy, 400012, Cluj-Napoca, Romania

Download Full Article PDF

The aim of the present study was to evaluate the pharmaceutical market of analgesic medicines in Romania during 2011 - 2015. A retrospective descriptive analysis was conducted on sales data provided by IQVIA (formerly IMS Health). Data corresponded to the volume of analgesic sales in hospital and retail pharmacies, split up in units and value (EUR), in prescription only (POM) and over-the-counter (OTC) medication and by region. Data was estimated to cover 95% of the Romanian market. From 2011 to 2015, the analgesic pharmaceutical market increased by 18.7% in value and by 6.1% in units. It was mainly assured by the retail distribution channel (95%), both for OTC and POM. The highest sales (6.3 units/capita, 12.3 EUR/capita) were found for the capital, Bucharest, while the lowest for counties of the North-East region of Romania (3.5 units/capita, 6.0 EUR/capita). In the context of an increasing analgesic market, programs that promote rational use of these medicines should be a priority at present for the Romanian healthcare system.